Sirtuin 1 at the pinnacle of metabolic control

© 2012 EPFL
© 2012 EPFL
Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+? (Review) - Sirtuin 1 (SIRT1) is an evolutionarily conserved NAD+-dependent deacetylase that is at the pinnacle of metabolic control, all the way from yeast to humans. SIRT1 senses changes in intracellular NAD+ levels, which reflect energy level, and uses this information to adapt the cellular energy output such that it matches cellular energy requirements. The changes induced by SIRT1 activation are generally (but not exclusively) transcriptional in nature and are related to an increase in mitochondrial metabolism and antioxidant protection. These attractive features have validated SIRT1 as a therapeutic target in the management of metabolic disease and prompted an intensive search to identify pharmacological SIRT1 activators. In this review, Johan Auwerx and Carles Cantó ( Laboratory of Integrative Systems Physiology LISP) first give an overview of the SIRT1 biology with a particular focus on its role in metabolic control. Then they analyze the pros and cons of the current strategies used to activate SIRT1 and explore the emerging evidence indicating that modulation of NAD+ levels could provide an effective way to achieve such goals. Carles Cantó and Johan Auwerx, Pharmacological Reviews January 2012 vol.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.



Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience